Author: Jason Markwell

About Jason Markwell

Jason Markwell is a leading intellectual property litigator in Canada. He represents domestic and multinational corporations in a wide-range of industries, including life sciences, technology, financial services, manufacturing, mining and energy. He is well-known for his work on behalf of innovative pharmaceutical and biotechnology companies in patent infringement and regulatory disputes. He also provides advice in regard to the protection and enforcement of trade marks, copyright and trade secrets.

Analysis

Breaking News from the WTO: Limited TRIPS Waiver for COVID-19 Vaccines

Close up of Vials and Syringes with Covid-19 vaccine are displayed on a tray during vaccination.

On June 17, the 2022 Ministerial Conference of the World Trade Organization (“WTO”) issued a decision [PDF] pursuant to the Agreement on Trade-related Aspects of Intellectual Property Rights (“TRIPS Agreement”) and allowed certain members to use patented inventions for the production and supply of COVID-19 vaccines in specific circumstances (“Ministerial Decision”).

Continue reading »
Analysis, IP Litigation

Sedona Conference 2022: Practical Recommendations on Protecting Trade Secrets in Litigation

Abstract business icons over a laptop

The Sedona Conference Working Group recently issued some practical recommendations in their publication “Commentary on Protecting Trade Secrets in Litigation About Them”.[1] The purpose of this article is to provide a brief overview of the guidelines developed by this group and which we recommend you consider in your current and future litigation.

Continue reading »